Steroids may help arthritis sufferers

BY CELIA HALL

Medical Editor

Thousands of people who suffer severely from rheumatoid arthritis are set to benefit from a drug treatment, abandoned 30 years ago, which can halt their disease.

Researchers are confident that a regular low dose of steroids can stop the progression of the disease in the joints and may even prevent damage from starting.

The dramatic results of a two-year study on bone-damage prevention were given yesterday by Dr John Kirwan of Bristol University's Rheumatology Unit in a key paper at the annual meeting of the British Society of Rheumatology in Glasgow.

Dr Kirwan and Dr Margaret Byron, of Stoke Mandeville Hospital, developed a strategy of low-dose corticosteroids after a review of steroid treatments over the past 40 years.

Dr Kirwan said yesterday that while there were treatments to ease pain from rheumatoid arthritis - inflammation and swelling of the joints - there was no cure. There is nothing to help the underlying disease, which, in about half of patients, goes on to destroy the lining in the joints causing great pain and leading to osteoarthritis.

In the Fifties, doctors began to use steroids to treat the symptoms of rheumatoid arthritis, but, increasingly, high doses were needed over the months, which themselves caused unacceptable side effects. The treatment was abandoned.

In these early studies, X-rays were taken to monitor the patients' disease. When Dr Kirwan looked again at the X-rays and re-analysed the data, he found that steroids slowed the progression of the disease in the joints.

"These doctors were not looking at preventing the disease, but for methods of relieving the symptoms. What we have done is to establish a low fixed dose of steroids, which gives relief from pain in the first few months."

Then, instead of increasing the dose when the steroids no long give pain relief, the doctors treat patients with established drugs to give relief from pain while the fixed-dose steroids continue to prevent damage in the joints.

Most of the 128 patients in the trial, aged 18 to 70, had advanced disease in their joints which X-rays now show has been halted. But a small number were still at the stage of inflammation. During the two-year trial, the patients have not gone on to the joint damage which would have been expected.

Dr Kirwan said they had been discussing the success of the trial in recent months with colleagues internationally, and Swedish doctors are about to launch a trial using an even lower dose of steroids.

While high doses of steroids can cause heart disease, diabetes, obesity and thin bones, low doses can cause thinning of the skin which makes people bruise easily.

"There have been some side effects, but these have been minimal." Dr Kirwan said he believed the low-dose steroid treatment would be adopted around the world. About one in 50 people suffer from rheumatoid arthritis in Britain.

Start your day with The Independent, sign up for daily news emails
Voices
Barn owls are among species that could be affected
charity appeal
Sport
After another poor series in Sri Lanka, Alastair Cook claimed all players go through a lean period
cricketEoin Morgan reportedly to take over ODI captaincy as ECB finally wield the axe
Life and Style
food + drink
Arts and Entertainment
a clockwork orange, stanley kubrick
film
PROMOTED VIDEO
Have you tried new the Independent Digital Edition apps?
ebooks
ebooksA year of political gossip, levity and intrigue from the sharpest pen in Westminster
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs General

Recruitment Genius: Finance Director

£65000 - £80000 per annum: Recruitment Genius: Finance Director required to jo...

Recruitment Genius: Medico-Legal Assistant

£15000 - £25000 per annum: Recruitment Genius: This is a unique opportunity fo...

Ashdown Group: (PHP / Python) - Global Media firm

£50000 per annum + 26 days holiday,pension: Ashdown Group: A highly successful...

The Jenrick Group: Quality Inspector

£27000 per annum + pension + holidays: The Jenrick Group: A Quality Technician...

Day In a Page

Homeless Veterans appeal: 'You look for someone who's an inspiration and try to be like them'

Homeless Veterans appeal

In 2010, Sgt Gary Jamieson stepped on an IED in Afghanistan and lost his legs and an arm. He reveals what, and who, helped him to make a remarkable recovery
Could cannabis oil reverse the effects of cancer?

Could cannabis oil reverse effects of cancer?

As a film following six patients receiving the controversial treatment is released, Kate Hilpern uncovers a very slippery issue
The Interview movie review: You can't see Seth Rogen and James Franco's Kim Jong Un assassination film, but you can read about it here

The Interview movie review

You can't see Seth Rogen and James Franco's Kim Jong Un assassination film, but you can read about it here
Serial mania has propelled podcasts into the cultural mainstream

How podcasts became mainstream

People have consumed gripping armchair investigation Serial with a relish typically reserved for box-set binges
Jesus Christ has become an unlikely pin-up for hipster marketing companies

Jesus Christ has become an unlikely pin-up

Kevin Lee Light, aka "Jesus", is the newest client of creative agency Mother while rival agency Anomaly has launched Sexy Jesus, depicting the Messiah in a series of Athena-style poses
Rosetta space mission voted most important scientific breakthrough of 2014

A memorable year for science – if not for mice

The most important scientific breakthroughs of 2014
Christmas cocktails to make you merry: From eggnog to Brown Betty and Rum Bumpo

Christmas cocktails to make you merry

Mulled wine is an essential seasonal treat. But now drinkers are rediscovering other traditional festive tipples. Angela Clutton raises a glass to Christmas cocktails
5 best activity trackers

Fitness technology: 5 best activity trackers

Up the ante in your regimen and change the habits of a lifetime with this wearable tech
Paul Scholes column: It's a little-known fact, but I have played one of the seven dwarves

Paul Scholes column

It's a little-known fact, but I have played one of the seven dwarves
Fifa's travelling circus once again steals limelight from real stars

Fifa's travelling circus once again steals limelight from real stars

Club World Cup kicked into the long grass by the continued farce surrounding Blatter, Garcia, Russia and Qatar
Frank Warren column: 2014 – boxing is back and winning new fans

Frank Warren: Boxing is back and winning new fans

2014 proves it's now one of sport's biggest hitters again
Jeb Bush vs Hillary Clinton: The power dynamics of the two first families

Jeb Bush vs Hillary Clinton

Karen Tumulty explores the power dynamics of the two first families
Stockholm is rivalling Silicon Valley with a hotbed of technology start-ups

Stockholm is rivalling Silicon Valley

The Swedish capital is home to two of the most popular video games in the world, as well as thousands of technology start-ups worth hundreds of millions of pounds – and it's all happened since 2009
Did Japanese workers really get their symbols mixed up and display Santa on a crucifix?

Crucified Santa: Urban myth refuses to die

The story goes that Japanese store workers created a life-size effigy of a smiling "Father Kurisumasu" attached to a facsimile of Our Lord's final instrument of torture
Jennifer Saunders and Kate Moss join David Walliams on set for TV adaptation of The Boy in the Dress

The Boy in the Dress: On set with the stars

Walliams' story about a boy who goes to school in a dress will be shown this Christmas